Today, Hamilton, MolGen, and EWC Diagnostics announce their strategic partnership to scale up SARS-CoV-2 testing capacity in the Netherlands.

Since the outbreak of the COVID-19 pandemic in Europe, demand for SARS-CoV-2 detection tests has significantly increased. In order to increase testing capacity, the Dutch government, through the Ministry of Health, Welfare and Sport, invited commercial organizations to respond to a tender released this summer.

PathoFinder and EWC Diagnostics announce their collaboration to rapidly advance the expansion of COVID-19 testing capacity in the Netherlands by providing the Dutch government with complete sets of sampling materials and SARS-CoV-2 PCR kits.